Phytochemical antioxidants modulate mammalian cellular epigenome: Implications in health and disease

Antioxidants and Redox Signaling

Volumn 17, Issue 2, 2012, Pages 327-339

  Malireddy, Smitha ^a   Kotha, Sainath R ^a   Secor, Jordan D ^a   Gurney, Travis O ^a   Abbott, Jamie L ^a   Maulik, Gautam ^b   Maddipati, Krishna R ^c   Parinandi, Narasimham L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CURCUMIN; DAIDZEIN; DNA; EPIGALLOCATECHIN GALLATE; FLAVONOID; GENISTEIN; MICRORNA; MYRICETIN; PHOSPHODIESTERASE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CHROMATIN STRUCTURE; COLORECTAL CANCER; DIET; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HUMAN; LEUKEMIA CELL; M PHASE CELL CYCLE CHECKPOINT; MEDULLOBLASTOMA; METASTASIS; NECROSIS; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RING FINGER MOTIF;

ANIMALS; ANTIOXIDANTS; DISEASE; EPIGENESIS, GENETIC; EPIGENOMICS; GENOME; HEALTH; HUMANS;

ANIMALIA; MAMMALIA;

EID: 84862059860     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4600     Document Type: Review

References (82)

1. Abusnina A, Keravis T, Yougbare I, Bronner C, and Lugnier C. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res 55: 1677-1689, 2011.
2. Acamovic T and Brooker JD. Biochemistry of plant secondary metabolites and their effects in animals. Proc Nutr Soc 64: 403-412, 2005. (Pubitemid 41160771)
3. Adibhatla RM and Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12: 125-169, 2010.
4. Aggarwal BB and Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41: 40-59, 2009.
5. Arts IC and Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81: 317S-325S, 2005.
6. Baker JE. Oxidative stress and adaptation of the infant heart to hypoxia and ischemia. Antioxid Redox Signal 6: 423-429, 2004. (Pubitemid 38332600)
7. Bao J and Sack MN. Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors. Cell Mol Life Sci 67: 3073-3087, 2010.
8. Barnes PJ. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis 3: 235-243, 2009.
9. Barnes S, Prasain J, D'Alessandro T, Arabshahi A, Botting N, Lila MA, Jackson G, Janle EM, and Weaver CM. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct 2: 235-244, 2011.
10. Barry SP and Townsend PA. What causes a broken heart-molecular insights into heart failure. Int Rev Cell Mol Biol 284: 113-179, 2010.
11. Berletch JB, Liu C, Love WK, Andrews LG, Katiyar SK, and Tollefsbol TO. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 103: 509-519, 2008. (Pubitemid 351171921)
12. Bora-Tatar G, Dayangac-Erden D, Demir AS, Dalkara S, Yelekci K, and Erdem-Yurter H. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies. Bioorg Med Chem 17: 5219-5228, 2009.
13. Bors W and Michel C. Chemistry of the antioxidant effect of polyphenols. Ann N Y Acad Sci 957: 57-69, 2002. (Pubitemid 34721653)
14. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006. (Pubitemid 44043102)
15. Cheeseman KH. Mechanisms and effects of lipid peroxidation. Mol Aspects Med 14: 191-197, 1993.
16. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, and Chan PH. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14: 1505-1517, 2011.
17. Choi DY, Lee YJ, Hong JT, and Lee HJ. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res Bull 87: 144-153, 2012.
18. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, and Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501: 79-90, 2010.
19. Dell'Agli M, Busciala A, and Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res 63: 593-602, 2004. (Pubitemid 39078672)
20. Dinkova-Kostova AT. Phytochemicals as protectors against ultraviolet radiation: versatility of effects and mechanisms. Planta Med 74: 1548-1559, 2008.
21. Duthie SJ. Epigenetic modifications and human pathologies: cancer and CVD. Proc Nutr Soc 70: 47-56, 2011.
22. Ferguson LR and Schlothauer RC. The potential role of nutritional genomics tools in validating high health foods for cancer control: broccoli as example. Mol Nutr Food Res 56: 126-146, 2012.
23. Forester SC and Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 55: 844-854, 2011.
24. Fraga CG. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 59: 308-315, 2007. (Pubitemid 46763776)
25. Fritz KS, Galligan JJ, Smathers RL, Roede JR, Shearn CT, Reigan P, and Petersen DR. 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem Res Toxicol 24: 651-662, 2011.
26. Ghiringhelli F, Rebe C, Hichami A, and Delmas D. Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents. Anticancer Agents Med Chem 2012 Jan 31. [Epub ahead of print] PubMed PMID: 22292769.
27. Gilbert ER and Liu D. Flavonoids influence epigeneticmodifying enzyme activity: structure-function relationships and the therapeutic potential for cancer. Curr Med Chem 17: 1756-1768, 2010.
28. Gill PS and Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006. (Pubitemid 44726334)
29. Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, and Tombolini V. Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation. Mol Cancer 9: 305, 2010.
30. Guo RF and Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9: 1991-2002, 2007. (Pubitemid 47622351)
31. Hodek P, Trefil P, and Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139: 1-21, 2002. (Pubitemid 34135994)
32. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, and Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 141: 989S-1009S, 2011.
33. Huang J, Plass C, and Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 12: 1925-1956, 2011.
34. Janssen LJ, Catalli A, and Helli P. The pulmonary biology of isoprostanes. Antioxid Redox Signal 7: 244-255, 2005. (Pubitemid 40187941)
35. Kang J, Chen J, Shi Y, Jia J, and Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 69: 1205-1213, 2005. (Pubitemid 40417492)
36. Khan SI, Aumsuwan P, Khan IA, Walker LA, and Dasmahapatra AK. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chem Res Toxicol 25: 61-73, 2012.
37. Kim HJ and Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3: 166-179, 2011.
38. Kim J, Lee HJ, and Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 112: 1415-1430, 2010.
39. Korkina L, Kostyuk V, De Luca C, and Pastore S. Plant phenylpropanoids as emerging anti-inflammatory agents. Mini Rev Med Chem 11: 823-835, 2011.
40. Kulkarni AC, Kuppusamy P, and Parinandi N. Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid Redox Signal 9: 1717-1730, 2007. (Pubitemid 47462974)
41. Kurdistani SK. Histone modifications in cancer biology and prognosis. Prog Drug Res 67: 91-106, 2011.
42. Lambert JD and Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65-72, 2010.
43. Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mouzon S, and Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 15: 3061-3100, 2011.
44. Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, and Rajasekaran SA. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 11: 144, 2011.
45. Lee WJ, Chen YR, and Tseng TH. Quercetin induces FasLrelated apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep 25: 583-591, 2011.
46. Li G and Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 21: 175-186, 2011.
47. Li Q and Chen H. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis. Epigenetics 6: 849-852, 2011.
48. Li Y and Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 17: 2141-2151, 2010.
49. Li Y, Yuan YY, Meeran SM, and Tollefsbol TO. Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells. Mol Cancer 9: 274, 2010.
50. Link A, Balaguer F, and Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80: 1771-1792, 2010.
51. Manach C, Mazur A, and Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16: 77-84, 2005. (Pubitemid 40333370)
52. Meeran SM, Patel SN, Chan TH, and Tollefsbol TO. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila) 4: 1243-1254, 2011.
53. Minko IG, Kozekov ID, Harris TM, Rizzo CJ, Lloyd RS, and Stone MP. Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol 22: 759-778, 2009.
54. Mittal A, Piyathilake C, Hara Y, and Katiyar SK. Exceptionally high protection of photocarcinogenesis by topical application of (-)- epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 5: 555-565, 2003. (Pubitemid 38045092)
55. Nandakumar V, Vaid M, and Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32: 537-544, 2011.
56. Nicholson SK, Tucker GA, and Brameld JM. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br J Nutr 103: 1398-1403, 2010.
57. Nicholson SK, Tucker GA, and Brameld JM. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 67: 42-47, 2008. (Pubitemid 351185355)
58. Nihal M, Roelke CT, and Wood GS. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG). Pharm Res 27: 1103-1114, 2010.
59. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15: 1911-1926, 2011.
60. Panickar KS and Anderson RA. Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. Int J Mol Sci 12: 8181-8207, 2011.
61. Pereira CV, Nadanaciva S, Oliveira PJ, and Will Y. The contribution of oxidative stress to drug-induced organ toxicity and its detection in vitro and in vivo. Expert Opin Drug Metab Toxicol 8: 219-237, 2012.
62. Perron NR and Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53: 75-100, 2009.
63. Perron NR, Wang HC, Deguire SN, Jenkins M, Lawson M, and Brumaghim JL. Kinetics of iron oxidation upon polyphenol binding. Dalton Trans 39: 9982-9987, 2010.
64. Piaz FD, Vassallo A, Rubio OC, Castellano S, Sbardella G, and De Tommasi N. Chemical biology of histone acetyltransferase natural compounds modulators. Mol Divers 15: 401-416, 2011.
65. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2: 351-374, 2008.
66. Reuter S, Gupta SC, Park B, Goel A, and Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6: 93-108, 2011.
67. Santos-Reboucas CB and Pimentel MM. Implication of abnormal epigenetic patterns for human diseases. Eur J Hum Genet 15: 10-17, 2007. (Pubitemid 44921660)
68. Scalbert A, Johnson IT, and Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr 81: 215S-217S, 2005.
69. Siow RC and Mann GE. Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol Aspects Med 31: 468-477, 2010.
70. Spatafora C and Tringali C. Natural-derived polyphenols as potential anticancer agents. Anticancer Agents Med Chem 2012 Jan 31. [Epub ahead of print] PubMed PMID 22292761.
71. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, and Schini-Kerth VB. Vascular protection by dietary polyphenols. Eur J Pharmacol 500: 299-313, 2004. (Pubitemid 39304017)
72. Sun H, Yang X, Zhu J, Lv T, Chen Y, Chen G, Zhong L, Li Y, Huang X, Huang G, and Tian J. Inhibition of p300-HAT results in a reduced histone acetylation and down-regulation of gene expression in cardiac myocytes. Life Sci 87: 707-714, 2010.
73. Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2: 1231-1246, 2010.
74. Usatyuk PV and Natarajan V. Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res 83: 45-55, 2012.
75. Vanhees K, Coort S, Ruijters EJ, Godschalk RW, van Schooten FJ, and Barjesteh van Waalwijk, van Doorn-Khosrovani S. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J 25: 797-807, 2011.
76. Visioli F, De La Lastra CA, Andres-Lacueva C, Aviram M, Calhau C, Cassano A, D'Archivio M, Faria A, Fave G, Fogliano V, Llorach R, Vitaglione P, Zoratti M, and Edeas M. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 51: 524-546, 2011.
77. Waggoner D. Mechanisms of disease: epigenesis. Semin Pediatr Neurol 14: 7-14, 2007.
78. Wong CP, Nguyen LP, Noh SK, Bray TM, Bruno RS, and Ho E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol Lett 139: 7-13, 2011.
79. Wongcharoen W and Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133: 145-151, 2009.
80. Wood LG, Wark PA, and Garg ML. Antioxidant and antiinflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 13: 1535-1548, 2010.
81. Yao H and Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol 254: 72-85, 2011.
82. Zhang Y and Chen H. Genistein, an epigenome modifier during cancer prevention. Epigenetics 6: 888-891, 2011.